A Study of Prexasertib (LY2606368) in Combination With Ralimetinib in Participants With Advanced or Metastatic Cancer

The main purpose of this study is to evaluate the safety of the study drug prexasertib in combination with ralimetinib in participants with advanced or metastatic cancer.本研究的主要目的为评估试验药物普雷塞替尼（prexasertib）与雷利米替尼（ralimetinib）联合使用在晚期或转移性癌症受试者中的安全性。